These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quinolone pharmacokinetics and metabolism. Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of quinolones in renal insufficiency. Fillastre JP; Leroy A; Moulin B; Dhib M; Borsa-Lebas F; Humbert G J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213 [TBL] [Abstract][Full Text] [Related]
4. Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis. Cardey J; Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Fourtillan JP; Beauchant M Eur J Clin Pharmacol; 1987; 33(5):469-72. PubMed ID: 3480805 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule. Wise R; Griggs D; Andrews JM Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid. Sambatakou H; Giamarellos-Bourboulis EJ; Galanakis N; Giamarellou H Int J Antimicrob Agents; 2001 Nov; 18(5):441-4. PubMed ID: 11711259 [TBL] [Abstract][Full Text] [Related]
7. Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis. Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Beauchant M Eur J Clin Pharmacol; 1989; 37(3):261-5. PubMed ID: 2612541 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and dose adaptation of ofloxacine, pefloxacine and ciprofloxacine during haemodialysis and continuous ambulatory peritoneal dialysis]. Daniel JP; Moulin B; Christmann D Ann Pharm Fr; 2004 May; 62(3):177-85. PubMed ID: 15243351 [TBL] [Abstract][Full Text] [Related]
9. Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis. Orlando R; Sawadogo A; Miglioli PA; Cappellazzo MG; Palatini P Chemotherapy; 1992; 38(1):1-6. PubMed ID: 1617997 [TBL] [Abstract][Full Text] [Related]
10. [Excretion of fluoroquinolones into saliva]. Kelentey BA; Kelentey BJ; Fekete I; Kozma J Fogorv Sz; 1995 Sep; 88(9):293-7. PubMed ID: 8522025 [TBL] [Abstract][Full Text] [Related]
11. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin. Frost RW; Lettieri JT; Krol G; Shamblen EC; Lasseter KC Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404 [TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour. Giamarellou H; Kanellas D; Kavouklis E; Petrikkos G; Gabriel L Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):293-7. PubMed ID: 8513819 [TBL] [Abstract][Full Text] [Related]
17. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones. Blum RA Am J Med; 1992 Apr; 92(4A):18S-21S. PubMed ID: 1316065 [TBL] [Abstract][Full Text] [Related]
18. The comparative pharmacokinetics of five quinolones. Wise R; Lister D; McNulty CA; Griggs D; Andrews JM J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of 4-fluoroquinolones permeation into saliva. Kozjek F; Suturkova LJ; Antolic G; Grabnar I; Mrhar A Biopharm Drug Dispos; 1999 May; 20(4):183-91. PubMed ID: 10440793 [TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin). Alestig K Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]